Free Newsletter
Mass vaccination program could target schools
The U.S. government has yet to say whether or not it will roll out a mass vaccination program against swine flu this fall, but it appears increasingly likely. Health and Human Services Secretary Kathleen Sebelius says that schools will be a logical place to start.
"If you think about vaccinating kids, schools are the logical place," Sebelius told the Associated Press. Young people are directly threatened by swine flu. The World Health Organization says that roughly half of the 160 people confirmed killed by new flu were young and healthy. Schools are also ground zero for a pandemic; where children spread the flu to each other and then take it home.
"We can always sort of back off," Sebelius said of the flu's changing severity. "But we can't wait til October hits and say, 'Oh my heavens, what are we going to do?'"
- read the report from RedOrbit
ALSO: If you look around the world, you'll see tremendous confusion over how to prioritize people for a vaccination program. In the UK, healthcare workers and children will be first in line. Report
Related Articles:
WHO declares first full-scale pandemic in 41 years
Four big vax makers charge ahead with swine flu programs
Billions budgeted for swine flu as programs launch
Comments
It's very sad that parents avoid vaccinating their children.
This could be a good opportunity to demonstrate the effectiveness of needle-free injection.
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




